Loading...

VRTX VERTEX PHARMACEUTICALS INC Business Restructuring 8-K Filing

VRTX

VRTX

VERTEX PHARMACEUTICALS INC

(VRTX)

2024 8-K

FDA Application Submitted

Financial Results Report

Financial Results Report

Financial Statements

Impairment Charge

Management Changes

Financial Results

Lease Extension

Financial Results Announcement

Annual Meeting Voting Results

Financial Results

Merger Agreement

Financial Results Announcement

FDA Approval and Pricing An...

Appointment of Nancy Thornb...

Financial Results

Appointment of Director

Financial Results

Annual Meeting Voting Results

Financial Results Announcement

External Links:

Vertex Pharmaceuticals has extended its leases for approximately 1.1 million square feet of office and lab space in Boston until June 30, 2044, with options for further extensions.

AI Assistant

VERTEX PHARMACEUTICALS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.